Heat Biologics Inc reports results for the quarter ended in June - Earnings Summary

Scorpius Holdings

11/08/2021 22:09

* Heat Biologics Inc  HTBX.OQ  reported a quarterly adjusted
loss of 26 cents​​ per share for the quarter ended in June. The
mean expectation of five analysts for the quarter was for a loss
of 30 cents per share.
* Revenue fell 22.5% to $459.49 thousand from a year ago; 
analysts expected $600.00 thousand. 
* The mean earnings estimate of analysts had risen by about 1.3%
in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Heat Biologics Inc shares had fallen by 2.7% this quarter and
gained 22.2% so far this year.
* The company reported a quarterly loss of $6.54 million.
* Wall Street's median 12-month price target for Heat Biologics
Inc is $22.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated August 11 at 09:09 p.m.  ​All
figures in US dollars unless otherwise stated